These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37676267)
1. Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature. Kang Y; Zhen H; Ma N; Zhao H; Cao B J Cancer Res Clin Oncol; 2023 Nov; 149(17):16239-16246. PubMed ID: 37676267 [TBL] [Abstract][Full Text] [Related]
2. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review. Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308 [TBL] [Abstract][Full Text] [Related]
3. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. Williams TJ; Benavides DR; Patrice KA; Dalmau JO; de Ávila AL; Le DT; Lipson EJ; Probasco JC; Mowry EM JAMA Neurol; 2016 Aug; 73(8):928-33. PubMed ID: 27271951 [TBL] [Abstract][Full Text] [Related]
4. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis. Larkin J; Chmielowski B; Lao CD; Hodi FS; Sharfman W; Weber J; Suijkerbuijk KPM; Azevedo S; Li H; Reshef D; Avila A; Reardon DA Oncologist; 2017 Jun; 22(6):709-718. PubMed ID: 28495807 [TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitor therapy-associated encephalitis: a case series and review of the literature. Stuby J; Herren T; Schwegler Naumburger G; Papet C; Rudiger A Swiss Med Wkly; 2020 Nov; 150():w20377. PubMed ID: 33232507 [TBL] [Abstract][Full Text] [Related]
6. Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review. Zafar Z; Vogler C; Hudali T; Bhattarai M Clin Med Res; 2019 Jun; 17(1-2):29-33. PubMed ID: 31160476 [TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature review. Palmieri VE; Roviello G; Catalano M; D'Angelo A; Vannini G; Buttitta E; Mini E Immunotherapy; 2022 May; 14(7):505-510. PubMed ID: 35380054 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune-related encephalitis during treatment with nivolumab for advanced head and neck cancer: a case report. Guidi A; Violati M; Blasi M; Ferrari E; Luciani A; Codecà C; Ferrari D Tumori; 2020 Dec; 106(6):NP23-NP28. PubMed ID: 32851941 [TBL] [Abstract][Full Text] [Related]
10. Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report. Taillefer VT; Pigeon M; Chen M; Larochelle C; Florescu M; Bélanger K; Adam JP J Oncol Pharm Pract; 2020 Sep; 26(6):1538-1543. PubMed ID: 32063105 [TBL] [Abstract][Full Text] [Related]
11. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment. Bir Yucel K; Sutcuoglu O; Yazıcı O; Yıldız Y; Şenol E; Uner A J Oncol Pharm Pract; 2023 Apr; 29(3):760-763. PubMed ID: 35938177 [TBL] [Abstract][Full Text] [Related]
12. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report. Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173 [TBL] [Abstract][Full Text] [Related]
13. Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report. Kopecký J; Kubeček O; Geryk T; Slováčková B; Hoffmann P; Žiaran M; Priester P J Med Case Rep; 2018 Sep; 12(1):262. PubMed ID: 30217214 [TBL] [Abstract][Full Text] [Related]